Abstract bekijken

Deze abstract is toegekend aan sessie AOB Free Papers 1
Type presentatieOral presentation
TitelTherapeutic Drug Monitoring of Adalimumab in Paediatric non-infectious Uveitis: A Retrospective Analysis
DoelTo evaluate the use of therapeutic drug monitoring (TDM) of adalimumab in children with chronic non-infectious uveitis (NIU).
MethodesChildren with chronic NIU diagnosed under the age of 16, treated with adalimumab, with (group 1) or without (group 2) concomitant immunomodulating treatment (IMT), with at least one available serum adalimumab trough level (TL) and anti-adalimumab antibody (AAA) level were included in this retrospective cohort study. Controlled uveitis was defined as an anterior chamber activity ≤0.5 cells on ≤2 steroid eye drops per day.
ResultatenA total of 37 children (73 eyes) treated with adalimumab for NIU were included (median age, 7.4 years; range, 2.2–13.8). During a median duration of 29 months (range 5-79), 200 TL were measured, with a median concentration of 13.4 µg/ml (range 0–33), and TDM-based therapeutic adjustments were performed in 22 patients (59.5%). In group 1 (n=28), treatment was escalated in 9 patients (32.1%), resulting in increased adalimumab levels (median +4.1 µg/ml, range [-0.7; +15.6]) in 7 patients (87.5%), and regained uveitis control in 5 of 8 patients (62.5%). In group 2 (n=9), 4 patients developed primary treatment failure, with TL <0.5 µg/ml and elevated AAA levels. In 3 of the remaining 5 patients, treatment adjustments (both escalation and taper) were made.
ConclusieTDM of adalimumab is a promising tool to optimise the clinical outcome and limit treatment related side effects in pediatric uveitis.
BelangenverstrengelingNee
Auteurs 1
NaamPARK
InitialenC
InstituutDpt of Ophthalmology (Ghent UH)
StadGhent
Auteurs 2
NaamBONROY
InitialenC
InstituutDpt of Clinical Biology (Ghent UH)
StadGhent
Auteurs 3
NaamDEHOORNE
InitialenJL
InstituutDpt of Pediatric Rheumatology (Ghent UH)
StadGhent
Auteurs 4
NaamKREPS
InitialenEO
InstituutDpt of Ophthalmology (Ghent UH)
StadGhent
top ^